Adjuvant Systemic Therapy in High Risk Solitary Bone Plasmacytoma: Results of the UK Randomised Phase III IDRIS Study (CR UK/14/032)

被引：1

作者：

Ediriwickrema, Kushani ^{[1
,2
]}

Rabin, Neil K. ^{[3
]}

D'Sa, Shirley ^{[3
]}

Jackson, Graham ^{[4
]}

Hoskin, Peter ^{[5
]}

Gallop-Evans, Eve ^{[6
]}

Diez, Patricia ^{[7
]}

Parbutt, Catherine ^{[8
]}

Lopes, Andre ^{[1
,2
]}

Galani, Sevasti ^{[1
,2
]}

Clifton-Hadley, Laura ^{[1
,2
]}

Edwards, Darren ^{[1
,2
]}

Tezver, Husne Timur ^{[1
,2
]}

de Tute, Ruth M. ^{[9
]}

Bates, Andrew ^{[10
]}

Owen, Roger G. ^{[8
]}

机构：

[1] UCL, Canc Res UK, London, England

[2] UCL, UCL Canc Trials Ctr, London, England

[3] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England

[4] Freeman Rd Hosp, Dept Haematol, Newcastle Upon Tyne, Tyne & Wear, England

[5] Mt Vernon Hosp, London, England

[6] Velindre Canc Ctr, Cardiff, Wales

[7] Natl Radiotherapy Trials Qual Assurance Grp, Northwood, Middx, England

[8] St James Univ Hosp, Leeds, W Yorkshire, England

[9] St James Univ Hosp, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England

[10] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England

来源：

关键词：

D O I：

10.1182/blood-2022-158528

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

653

引用

页码：12626 / 12627

页数：2